CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 108 filers reported holding CYMABAY THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,898,314 | +56.9% | 798,009 | +15.3% | 0.01% | +50.0% |
| Q2 2023 | $7,581,791 | +58.4% | 692,401 | +26.1% | 0.01% | +60.0% |
| Q1 2023 | $4,787,664 | +184.7% | 549,044 | +104.7% | 0.01% | +150.0% |
| Q4 2022 | $1,681,583 | +113.9% | 268,195 | +19.4% | 0.00% | +100.0% |
| Q3 2022 | $786,000 | +0.5% | 224,613 | -15.3% | 0.00% | 0.0% |
| Q2 2022 | $782,000 | -19.0% | 265,341 | -14.5% | 0.00% | 0.0% |
| Q1 2022 | $965,000 | +15.6% | 310,282 | +25.7% | 0.00% | 0.0% |
| Q4 2021 | $835,000 | -34.4% | 246,788 | -29.2% | 0.00% | 0.0% |
| Q3 2021 | $1,273,000 | -51.1% | 348,698 | -41.6% | 0.00% | -50.0% |
| Q2 2021 | $2,602,000 | -40.1% | 596,727 | -37.6% | 0.00% | -50.0% |
| Q1 2021 | $4,343,000 | -40.0% | 956,521 | -24.1% | 0.00% | -33.3% |
| Q4 2020 | $7,237,000 | -40.7% | 1,260,749 | -25.2% | 0.01% | -50.0% |
| Q3 2020 | $12,196,000 | +3.2% | 1,684,486 | -50.2% | 0.01% | -14.3% |
| Q2 2020 | $11,815,000 | +229.8% | 3,385,172 | +39.9% | 0.01% | +133.3% |
| Q1 2020 | $3,582,000 | -9.6% | 2,419,884 | +19.7% | 0.01% | +20.0% |
| Q4 2019 | $3,962,000 | +11.9% | 2,021,552 | +192.2% | 0.01% | +25.0% |
| Q3 2019 | $3,542,000 | +110.8% | 691,919 | +194.8% | 0.00% | +100.0% |
| Q2 2019 | $1,680,000 | +937.0% | 234,675 | +1822.9% | 0.00% | – |
| Q1 2019 | $162,000 | +97.6% | 12,204 | +16.6% | 0.00% | – |
| Q4 2018 | $82,000 | – | 10,466 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saturn V Capital Management LP | 1,629,464 | $14,208,926 | 10.61% |
| Lynx1 Capital Management LP | 1,369,927 | $11,945,763 | 9.96% |
| Versant Venture Management, LLC | 543,753 | $4,741,526 | 9.88% |
| Foresite Capital Management IV, LLC | 1,787,094 | $15,583,460 | 8.09% |
| Octagon Capital Advisors LP | 4,570,918 | $39,858,405 | 5.74% |
| ACUTA CAPITAL PARTNERS, LLC | 878,500 | $7,660,520 | 5.64% |
| TCG Crossover Management, LLC | 3,048,257 | $26,580,801 | 5.18% |
| Affinity Asset Advisors, LLC | 1,083,118 | $9,444,789 | 3.12% |
| Altium Capital Management LP | 620,000 | $5,406,400 | 3.00% |
| Bain Capital Life Sciences Investors, LLC | 2,500,000 | $21,800 | 2.72% |